Anzeige
Mehr »
Samstag, 21.06.2025 - Börsentäglich über 12.000 News
500 % Kursplus seit Januar. 462 g/t Goldgehalte. Mrd.-Investoren an Bord. Dieser finnische Junior wird heiß!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

NASDAQ Biotech 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
15:42Notable analyst calls this week: Sarepta, Cisco and UBS among top picks2
14:42Vertex posts additional trial data for type 1 diabetes therapy5
10:30SONDERMELDUNG bei Biontech: Könnte der Kurs am Montag komplett einbrechen - Das sagen die Experten!
01:36Structure Therapeutics Inc.: Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-26712
FrTevogen files to sell 30.73M shares of common stock for holders2
FrCARGO Therapeutics, Inc. - 8-K, Current Report2
FrIncyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions5
FrVertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake7
FrIonis (IONS) Announces Leadership Transition as R&D Veteran Richard Geary Prepares to Retire3
FrTruist Initiates PTC Therapeutics (PTCT) Coverage with Buy Rating on Drug Launches3
FrCiti Rates Protagonist Therapeutics (PTGX) as Buy Protagonists Drugs Opportunity2
FrAtea Pharmaceuticals, Inc. - 8-K, Current Report1
FrBiomea Fusion, Inc. - 8-K, Current Report1
Fr$100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today6
FrInozyme Pharma Inc.: Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders2
FrIncyte says FDA delays target action date for ruxolitinib cream3
FrFDA extends review period for Incyte's atopic dermatitis cream3
FrImmunityBio, Inc. - 8-K, Current Report5
FrUltragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)20NOVATO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
► Artikel lesen
FrWave Life Sciences präsentiert vielversprechende Daten zu Adipositas-Behandlung1
Weiter >>